EUVIMEDEUVIMED entdecken
Crossref

Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED

Qinglei Yin iD, Tianyi Zhu, Dalong Song, Sijie Fang iD, Huifang Zhou iD, Haixia Guan iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Qinglei Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Geriatric Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Graves Disease, Graves Ophthalmopathy, Immune Checkpoint Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guangzhou, China, Young Talent Support Project of Guangzhou Association for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Soluble immune checkpoints play an important role in peripheral tolerance that has seldom been investigated in Graves' disease (GD) and thyroid eye disease (TED).

Objective

The objective of this work is to examine the alteration of soluble immune checkpoints in GD and TED.

Methods

We performed a quantitative multiplex analysis of 17 immune checkpoint proteins in serum from 50 GD patients without TED, 28 GD patients with TED, and 40 healthy controls. The association with demographic, serologic, clinical features and 27 cytokines was analyzed. A follow-up was conducted in GD patients without TED. Functional outcomes of sLAG-3 and sGITR were assessed in cell cultures using rh-LAG3, rh-GITR, an antagonistic LAG-3 antibody, and an antagonistic GITR antibody.

Results

GD Patients with TED had distinct sICP and cytokine profiles compared with GD patients without TED. Active patients with TED exhibited elevation in the levels of sBTLA, sLAG-3, sGITR, sCD80, sCD86, and sPD-L1. Further, GD patients without TED with high sBTLA, sCD27, and sCD40 levels at baseline showed a better improvement in thyrotropin receptor antibody titers after antithyroid drug treatment. Adding recombinant human GITR and LAG-3 to peripheral blood mononuclear cell cultures resulted in increased inflammatory cytokine secretion and decreased anti-inflammatory cytokine secretion.

Conclusion

The present study uncovers disturbed soluble immune checkpoints and cytokines in GD patients with and without TED and may pave the way for novel immunological screening, allowing for identification of patients with TED at higher risk of developing active disease and patients with GD a better treatment response after antithyroid drug treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseGraves OphthalmopathyImmune Checkpoint ProteinsHumansFemaleMaleMiddle AgedAdultCytokinesTreatment OutcomeCase-Control StudiesFollow-Up StudiesBiomarkersAged

Stichwörter der Autor:innen

CASGraves' diseaseTRAb titerssoluble immune checkpointsthyroid eye disease

Substanzen

CytokinesImmune Checkpoint ProteinsBiomarkers

Autor:innen und Institutionen

  • Guangdong Geriatric Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
  • Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • Reproductive Medicine Center, Department of Obstetrics and Gynecology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
  • Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.

ORCID-Profile: Qinglei Yin, Sijie Fang, Huifang Zhou, Haixia Guan

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou, China
  • Young Talent Support Project of Guangzhou Association for Science and Technology

Zitieren

APA

Yin, Q., Zhu, T., Song, D., Fang, S., Zhou, H., & Guan, H. (2025). Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae763

Vancouver

Yin Q, Zhu T, Song D, Fang S, Zhou H, Guan H. Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae763

BibTeX
@article{Yin2025,
  author = {Yin, Qinglei and Zhu, Tianyi and Song, Dalong and Fang, Sijie and Zhou, Huifang and Guan, Haixia},
  title = {Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae763}
}
Kostenlos starten →